GL-59728

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameGL-59728

Drug Alias NameNS5b non-nucleoside inhibitor (Genelabs/Novartis)RNA polymerase inhibitor (Genelabs)NS5b non-nucleoside inhibitor (GSK/Novartis)GL-59728

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitorsBacterial DNA-directed RNA polymerase inhibitors

TargetsHepatitis C virus NS5B RNA-dependent RNA polymeraseBacterial DNA-directed RNA polymerase

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSwitzerlandUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenelabs Technologies Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovartis Ag Glaxosmithkline Plc Genelabs Technologies Inc

Active IndicationsN/A

Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A